Victoria Socha

DocwireNews

Patients with chronic kidney disease (CKD) and mineral bone disorder (MBD) face a high symptom burden, including fractures, vascular calcification, and cardiovascular disease, as well as increased risk of morbidity and mortality. According to Kosaku Nitta and colleagues, there are few data available on CKD-MBD among patients receiving peritoneal dialysis.The researchers conducted a data analysis to examine calcium and parathyroid hormone (PTH) control, as well as associations with mortality in patients on peritoneal dialysis. Results of the analysis were reported during a poster session at the American Society of Nephrology Kidney Week 2023 in a poster titled International Variations in Serum PTH and Calcium Levels and Their Mortality Associations in Peritoneal Dialysis Patients: Results From PDOPPS.Data from eight countries (Australia and New Zealand [A/NZ], Canada, Japan, Thailand, South Korea, the United Kingdom, and the United States) participating in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) 2014-2022 were included in the analysis. Eligible participants had received peritoneal dialysis for at least 3 months. Cox regression adjusted for potential confounders was used to examine the association between baseline PTH and albumin-adjusted calcium (calciumAlb) and all-cause mortality.Mean age of the eligible patients ranged from 54.6 years in South Korea to 63.5 years in Japan. PTH was measured at baseline in 12,642 patients, and serum calciumAlb was measured at baseline in 14,244 patients. Median PTH ranged from 161 pg/mL in Japan to 363 pg/mL in the United States. Mean calciumAlb ranged from 9.1 mg/dL in South Korea and the United States to 9.8 mg/dL in A/NZ.The relationship between PTH and mortality was U-shaped, with the lowest risk at PTH 300 to 599 pg/mL. The risk of mortality was nearly 20% higher at serum calciumAlb 9.6 mg/dL than at 8.4 mg/dL.&ldquo;A large proportion of peritoneal dialysis patients in the multinational study have calcium or PTH levels in ranges associated with substantially higher mortality,&rdquo; the authors said. &ldquo;These observations point to the need to substantially improve MBD management in peritoneal dialysis to optimize patient outcomes.&rdquo;Source: Nitta K, Bieber B, Karaboyas A, et al. International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: results from PDOPPS. TH-PO161. Abstract of a poster presented at the American Society of Nephrology Kidney Week 2023; November 2, 2023; Philadelphia, Pennsylvania.

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

PTH and Calcium Levels and Mortality in Peritoneal Dialysis Patients

ASN Kidney Week 2023

Researchers studied calcium and parathyroid hormone (PTH) control, as well as associations with mortality in patients on peritoneal dialysis. 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe